TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Cancergenetik i Stockholm AB
Closing information (x1000 DKK)
| Closing information | 2024/03 | 2023/03 | 2022/03 |
| Turnover |
0
|
969
|
1,449 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-191
|
205
|
208 |
| EBITDA |
-193
|
205
|
208 |
| Total assets |
359
|
489
|
327 |
| Current assets |
359
|
489
|
327 |
| Current liabilities |
126
|
50
|
18 |
| Equity capital |
233
|
419
|
299 |
| - share capital |
32
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Solvency |
64.9%
|
85.7%
|
91.4% |
| Turnover per employee |
0
|
969
|
1,449 |
| Profit as a percentage of turnover |
21.2%
|
14.4% | |
| Return on assets (ROA) |
-53.2%
|
41.9%
|
63.6% |
| Current ratio |
284.9%
|
978.0%
|
1816.7% |
| Return on equity (ROE) |
-82.0%
|
48.9%
|
69.6% |
| Change turnover |
-949
|
-361
|
-28 |
| Change turnover % |
-100%
|
-27%
|
-2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.